• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Lyra Therapeutics released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 391K and EPS of USD -15.3982
04:00
Lyra Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 25K (forecast USD 154.25K), actual EPS USD -3.3849 (forecast USD -5.255)
04:00
Oct14
Hanbury Brown's Rating and Target Price for Lyra Therapeutics
11:22
Oct6
Hanbury Brown Rates Healthcare Sector Stocks
19:46
Aug13
Lyra Therapeutics released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 183K (forecast USD 181.25K), actual EPS USD -5.5144 (forecast USD -5.5266)
03:00
Lyra Therapeutics released FY2025 Semi-Annual Earnings on August 12 EST, with actual revenue of USD 366 K and EPS of USD -12.0001
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 25 K, Net Income -5.984 M, EPS -3.3849

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 183 K, Net Income -7.437 M, EPS -5.5144

May28
Reverse Stock Split(EST)

1-for-50 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More